• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

sean.grimmond@unimelb.edu.au

Credentials


Position
Director, Collaborative Centre for Cancer Genomics
Centre for Cancer Research
Education
Bachelors Degree (Honours)
University of New England
PhD
The University of Queensland
ORCID

0000-0002-8102-7998

Prof Sean Grimmond

Director, Collaborative Centre for Cancer Genomics
Centre for Cancer Research

413 Scholarly works
35 Projects

HIGHLIGHTS

  • 2025

    Journal article

    Perioperative IDH inhibition in treatment-naive IDH-mutant glioma: a pilot trial
    DOI: 10.1038/s41591-025-03884-4
  • 2020

    Research grants (ARC, NHMRC, MRFF)

    Super-Next: Complete Genome Profiling for Cancer of Unknown Primary
  • 2020

    Research grants (ARC, NHMRC, MRFF)

    Evaluation of Fibroblastic Activation Protein Inhibitors (FAPI) as a Novel Radiopharmaceutical Targeting Cancer-Associated Fibroblasts for the Diagnosis and Treatment of Patients With Cancer of Unknown Primary: The FAPI-CUP Trial
  • 2020

    Research grants (ARC, NHMRC, MRFF)

    Dissecting the Mutational Landscapes, Cellular Ecosystems and Therapeutic Vulnerabilities of Pancreatic Cancer
  • 2015

    Journal article

    A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing
    DOI: 10.1038/ncomms10001
  • 2015

    Journal article

    Whole-genome characterization of chemoresistant ovarian cancer
    DOI: 10.1038/nature14410
  • 2015

    Journal article

    Whole genomes redefine the mutational landscape of pancreatic cancer
    DOI: 10.1038/nature14169
Sean Grimmond

Latest Honours,
Awards and Fellowships


2013
Royal Society Research Fellow - Wolfson Award 2013-2017, returned 2016 The Royal Society, UK
2012
NHMRC Fellowship (NHMRCF)
2011
Julian Wells Medallist - Genomics The University of Queensland
2011
Vice-Chancellor's Top 10 Q-Index Award The University of Queensland

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Abstract 7282: A comprehensive multiomics atlas of treatment-naïve breast cancer uncovers co-occurring tumor-immune ecosystems driving immune hot and cold phenotypes
    DOI: 10.1158/1538-7445.am2026-7282
  • 2026

    Journal article

    Abstract 44: scSubtype2.0: Predictor of breast cancer molecular subtypes at single cell resolution.
    DOI: 10.1158/1538-7445.am2026-44
  • 2026

    Journal article

    Endoscopic ultrasound molecular evaluation of pancreatic cancer trial to profile molecular landscape of inoperable pancreatic ductal adenocarcinoma.
    DOI: 10.1055/a-2733-1068
  • 2026

    Journal article

    KRAS internal tandem duplications and alternative driver variants in BRAF Val600Glu negative hairy cell leukemia
    DOI: 10.1080/10428194.2026.2615055
  • 2025

    Journal article

    Abstract B023: Temporally resolved proteomics identifies nidogen-2 as a co-target in pancreatic cancer that modulates fibrosis and therapy response
    DOI: 10.1158/1538-7445.canevol25-b023
  • 2025

    Journal article

    762MO Clinical whole genome and transcriptome sequencing for cancer of unknown primary: An Australian prospective observational study
    DOI: 10.1016/j.annonc.2025.10.1177
  • 2025

    Journal article

    Pathologist-initiated whole genome and transcriptome sequencing demonstrates diagnostic utility in resolving difficult-to-diagnose tumors
    DOI: 10.1186/s13073-025-01534-5
  • 2025

    Journal article

    Automated integration of multi-slice spatial transcriptomics data in 2D and 3D using VR-Omics
    DOI: 10.1186/s13059-025-03630-6

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224